Taquicardia ventricular recurrenteinforme de tres casos de radioablación cardíaca

  1. Gustavo Pozo Rodríguez 1
  2. Sandra Giselle Guardado González 1
  3. Eduardo Cabello Murillo 1
  4. Pedro Adaimi Hernández 1
  5. Raúl Díaz Fuentes 1
  6. Ana Isabel Milanes Gaillet 1
  7. Ángel Gaitán Simón 1
  8. Marta Manbz 1
  9. Paloma Botella Faus 1
  10. Daniel Rojo Navarrete 1
  11. José Pérez-Regadera Gómez 1
  1. 1 HU 12 de Octubre de Madrid
Revista:
Revista de Física Médica

ISSN: 1576-6632

Año de publicación: 2023

Volumen: 24

Número: 2

Páginas: 35-41

Tipo: Artículo

DOI: 10.37004/SEFM/2023.24.2.003 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Revista de Física Médica

Resumen

Este informe recoge los parámetros más relevantes que pueden influir en el resultado final de los tratamientos de ablación cardíaca con radioterapia tratados en nuestra institución hasta la fecha desde 2021. Dichos parámetros están relacionados con el estado general y comorbilidades del paciente, definición del CTV objetivo, inmovilización, IGRT y plan de tratamiento.

Referencias bibliográficas

  • Boda-Heggemann J., Blanck O. et al. Interdisciplinary clinical target volume generation for cardiac radioablation: Multicenter benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial. Int J Oncol Biol Phys j. ijrobp. 2021.01.028. DOI: https://doi.org/10.1016/j.ijrobp.2021.01.028
  • Blanck O., Buergy D. et al. Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA). Clin Res Cardiol .2020. 109:1319–1332. DOI: https://doi.org/10.1007/s00392-020-01650-9
  • Chin R., Hayase J. et al. Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience. J Interv Card Electrophysiol. 2021 Sep;61(3):535-543. DOI: https://doi.org/10.1007/s10840-020-00849-0.
  • Cuculich, P., Schill M. et al. Non-invasive Cardiac Radiation for Ablation of Ventricular Tachycardia. NEJM. 2017. 377:2325-2336. DOI: https://doi.org/10.1056/NEJMoa1613773.
  • Brownstein J., Afzal M. et al. Method and Atlas to Enable Targeting for Cardiac Radioablation Employing the American Heart Association Segmented Model. Int J Oncol Biol Phys. 2021. 111(1),178-185. DOI: https://doi.org/10.1016/j.ijrobp. 2021.03.051.
  • Pukala J, Johnson PB et al. Benchmarking of five commercial deformable image registration algorithms for head and neck patients. J Appl Clin Med Phys. 2016 May 8;17(3):25-40. DOI: https://doi.org/ 10.1120/jacmp.v17i3.5735.
  • Milo M., Offersen B. et al. Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups. Radiother Oncol. 2020 Sep;150:121-127. DOI: https://doi.org/10.1016/j.radonc.2020.06.015.
  • Feng M., Moran JM. et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):10-8. DOI: https://doi.org/10.1016/j.ijrobp.2009.10.058.
  • Knutson NC, Samson PP et al. Radiation Therapy Workflow and Dosimetric Analysis from a Phase 1/2 Trial of Noninvasive Cardiac Radioablation for Ventricular Tachycardia. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1114-1123. DOI: https://doi.org/10.1016/j.ijrobp.2019.04.005.
  • Wilke L., Andratschke N. et al. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol. 2019 Mar;195(3):193-198. English. DOI: https://doi.org/10.1007/s00066-018-1416-x.
  • Jumeau R., Ozsahin M. et al. Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions. Front Cardiovasc Med. 2020 Jun 25;7:108. DOI: https://doi.org/10.3389/fcvm.2020.00108.
  • Lydiard P., Blanck O. et al. A Review of Cardiac Radioablation (CR) for Arrhythmias: Procedures, Technology, and Future Opportunities. Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):783-800. DOI: https://doi.org/10.1016/j.ijrobp.2020.10.036.
  • Robinson CG, Samson PP et al. Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia. Circulation. 2019 Jan 15;139(3):313-321. DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.038261.
  • Ong CL., Verbakel WF. et al. Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e137-43. DOI: https://doi.org/10.1016/j.ijrobp.2011.12.014.
  • Manger R., Yock A. et al. Monitor Unit-Efficient Planning for Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery. Poster Viewing Abstract, V.96, Issue 2, Supplement, E649-E650, October, 2016. DOI: https://doi.org/10.1016/j.ijrobp.2016.06.2255
  • Miften M., Mihailidis D. et al. Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A Report of the AAPM TG-203†. Med Phys. 2019 Dec;46(12):e757-e788. doi:10.1002/mp.13838.
  • Gauter-Fleckenstein B., Israel CW. et al. DEGRO/DGK. DEGRO/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices. Strahlenther Onkol. 2015 May;191(5):393-404. DOI: https://doi.org/10.1007/s00066-015-0817-3.
  • Robinson C., Samson P. et al. Longer Term Results from a Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (ENCORE-VT). Int J Oncol Biol Phys. 2019. 105(3):682-682. DOI: https://doi.org/10.1016/j.ijrobp.2019.08.032.
  • Grimm J., LaCouture T. et al. Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy. J Appl Clin Med Phys. 2011 Feb 8;12(2):3368. DOI:https://doi.org/10.1120/jacmp.v12i2.3368.
  • Robinson CG, Samson PP et al. Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia. Circulation. 2019 Jan 15;139(3):313-321. DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.038261.
  • Le QT, Loo BW et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006 Oct;1(8):802-9. DOI: https://doi.org/10.1016/S1556-0864(15)30409-3.
Fuente de los datos: Dialnet